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their lymphoid colony-forming capacity and inducesAlbert Einstein College of Medicine
their capacity to form MEP colonies (Iwasaki et al., 2003).Cancer Research Center
These experiments also showed that altering the bal-1300 Morris Park Avenue
ance of lineage-restricted transcription factors can re-Bronx, New York 10461
verse commitment and that reprogramming involves not
just activation of novel gene expression programs but
also extinction of the original ones. At least in someSummary
cases, this involves direct transcription factor interac-
tions such as those between GATA-1 and PU.1 (an ETSStarting with multipotent progenitors, hematopoietic
family factor) (Cantor and Orkin, 2001; Graf, 2002).lineages are specified by lineage-restricted transcrip-
Which transcription factors determine the decision-tion factors. The transcription factors that determine
making process between lymphoid and myeloid cellthe decision between lymphoid and myeloid cell fates,
fates and how they do it remain largely unknown. Unlikeand the underlying mechanisms, remain largely un-
in adult bone marrow, where lymphoid and myeloid com-known. Here, we report that enforced expression of
partments branch early, the fetal liver contains bipotentC/EBP and C/EBP in differentiated B cells leads to
B cell/macrophage progenitors (B/M) (for review, seetheir rapid and efficient reprogramming into macro-
Katsura [2002]), suggesting that these two lineages arephages. C/EBPs induce these changes by inhibiting
closely related. It has also been shown that certain onco-the B cell commitment transcription factor Pax5, lead-
gene-immortalized B cell lines can be reprogrammeding to the downregulation of its target CD19, and syn-
into macrophages by the raf/ras oncogenes (Klinken etergizing with endogenous PU.1, an ETS family factor,
al., 1988) and by an activated form of the M-CSF receptorleading to the upregulation of its target Mac-1 and
(M-CSFR) (Borzillo et al., 1990). Although the cell conver-other myeloid markers. The two processes can be
sion frequencies appeared to be low, in both studies,uncoupled, since, in PU.1-deficient pre-B cells,
the resulting myelomonocytic cells had the same immu-C/EBPs induce CD19 downregulation but not Mac-1
noglobulin rearrangements as the original B lineageactivation. Our observations indicate that C/EBP and
cells. These changes must have therefore involved a remodel the transcription network of B cells into
complete shutdown of the B cell-specific gene expres-that of macrophages through a series of parallel and
sion program and its replacement by a macrophage-sequential changes that require endogenous PU.1.
specific gene expression program. How does this
happen?Introduction
B cell differentiation is initiated by the transcription
factors E2A (a helix-loop-helix protein) and EBF, inBlood cell formation is one of the classical systems in
whose absence B cells are arrested at a stage beforewhich to study mechanisms of vertebrate lineage deter-
DJ rearrangements. Together, these genes induce themination. Hematopoietic lineages are specified in a
transcription of many B cell-specific genes, includingstepwise process of binary decisions, starting with
that of the B cell commitment factor Pax5. From themultipotent progenitors, which branch into a common
pro-B cell stage onward, Pax5 (a paired domain tran-
lymphoid and a common myeloid progenitor that differ-
scription factor) activates the expression of genes such
entiate in turn into additional intermediate progenitors
as CD19 and blnk while suppressing lineage-inappropri-
(Akashi et al., 2000a, 2000b). Each lineage exhibits a ate genes such as M-CSFR (c-fms) and Notch-1 (Kee
distinct gene expression pattern that is laid down and and Murre, 2001; Schebesta et al., 2002). C/EBP (a
maintained by a set of more than a dozen lineage- bZip family transcription factor) may also play a role in
restricted transcription factors that are part of a “tran- B cell differentiation, since ablation of this factor, which
scription factor network” (Orkin, 2000; Sieweke and is expressed predominantly in mature cells of the B
Graf, 1998). Since random combinations of several of lineage (Cooper et al., 1994), leads to a decreased num-
these factors could, at least in principle, lead to far larger ber of B cells in the bone marrow (Chen et al., 1997). A
numbers of phenotypes than observed, there must be transcription factor that is important for both B cell and
mechanisms that ensure a highly coordinated control macrophage formation is PU.1, since mice defective in
of transcription factor network remodeling during com- this gene lack both lineages (reviewed in Schebesta et
mitment. This assumption is supported by enforced al. [2002]). This factor, which is expressed at lower levels
transcription factor expression experiments where, for in B cells than in macrophages (DeKoter and Singh,
example, ectopic expression of GATA-1 (a Zn finger 2000), has been implicated in B/M lineage decisions,
protein) in transformed as well as normal myeloid pre- since low levels of PU.1 expressed in PU.1/ fetal liver
cursor cells reprograms them into megakaryocytic/ery- precursors promote B cell differentiation, while high lev-
throid (MEP) cells, eosinophils, or mast cells, lineages els promote macrophage differentiation (DeKoter and
Singh, 2000). No transcription factors have yet been
shown to be uniquely required for macrophage forma-*Correspondence: graf@aecom.yu.edu
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tion, although C/EBP/ macrophages exhibit func- EYFP (Figures 2B and 2C). In bone marrow-derived
CD19 cells from CD19 ancestry mice infected withtional defects such as a decreased production of the
inflammatory response cytokine IL-12 (Screpanti et al., C/EBP/hCD4 virus, 65% of the hCD4 EYFP cells
downregulated CD19 and activated Mac-1 expression1995). In contrast, C/EBP/ mice lack granulocytes
(Zhang et al., 1997), a defect that can be rescued if within 5 days (Figure 2D), while control virus-infected
cells remained unchanged.C/EBP is inserted into the C/EBP locus (Jones et al.,
2002). In short, B cell fate is determined by E2A, EBF,
Pax5, and PU.1, while myelomonocytic cells (which in- Mature B Cells from the Spleen
clude both macrophages and granulocytes) are deter- Can Also Be Reprogrammed
mined by elevated levels of PU.1 as well as by C/EBP To determine whether mature B cells can also be repro-
and/or C/EBP. grammed, we tested B cells from the spleen of CD19
Here, we show that enforced expression of C/EBP ancestry mice. In these mice, 90% of the B cells are
and  in B cells leads to their rapid and efficient repro- EYFP, while, of the EYFP population, no cells were
gramming into macrophages. This occurs through a Mac-1 (Figure 2E). All EYFP cells were found to also
complex process that is initiated by the coordinated express the kappa chain, lambda chain, IgM, IgD, and/or
inhibition of Pax5 activity, resulting in the downregula- IgG (Figure 2F). Next, we isolated CD19 spleen cells,
tion of CD19, and the synergistic action between infected them with C/EBP, and seeded them on stroma
C/EBP and PU.1, resulting in the activation of macro- supplemented with cytokines. As shown in Figure 2G,
phage-specific genes. 31% of the cells became Mac-1 3 days after infection.
No phenotypic changes were seen in the control virus-
infected EYFP cells (data not shown). We concludeResults
that immunoglobulin-expressing cells derived from the
spleen can be reprogrammed although at lower efficien-Enforced C/EBP Expression Induces Mac-1
cies than B cell precursors from bone marrow.Expression in Primary B Cell Precursors
A retroviral approach was used to express myeloid tran-
scription factors in primary B cell precursors. As shown Reprogramming of B Cell Precursors In Vivo
in Figure 1A, the vectors encode either GFP or hCD4 To determine whether a B to M conversion can also be
alone (“control virus”) or C/EBP together with GFP/ observed in vivo, we isolated B220 B cell precursors
hCD4 (“C/EBP virus”). To obtain B cell progenitors, from a bone marrow pool of CD19 ancestry mice, in-
CD19 cells were purified from the bone marrow of fected two aliquots with either C/EBP/hCD4 virus or
C57Bl/6J mice using magnetic bead selection, typically with control virus for 6 hr, and injected them into two
yielding 99% CD19 cells (Figure 1B). Control virus- sublethally irradiated RAG2/c/ mice each. As shown
infected cells, grown under conditions that support both in Figures 2H and 2I, for one animal analyzed 6 days after
B cell and myeloid cell development, remained transplantation, 51% of the C/EBP-expressing, EYFP
CD19Mac-1 (Figure 1C). In contrast, cells infected cells were CD19Mac-1 in the bone marrow and 32%
with C/EBP downregulated CD19 and upregulated in the spleen. No reprogrammed myeloid cells were ob-
Mac-1, with60% of the cells becoming CD19Mac-1 served in an animal transplanted with control virus-
after 4 days (Figure 1D). No changes were seen in the infected cells (Figure 2J). Similar results were obtained
uninfected portion of the sample. The effect is also with the other pair of mice analyzed. The Mac-1 cells
C/EBP-specific, since cells infected with virus express- of the experimental mice were also Gr-1B220, and
ing the irrelevant FOG-1 transcription factor showed no about 80% were L-selectin. Most of the reprogrammed
changes (data not shown). The efficiency of the ob- cells also exhibited relatively low side scatter values,
served phenotypic conversion was dependent on the suggesting that the in vivo reprogrammed cells resem-
level of C/EBP, since the proportion of “nonrespond- ble monocytes but not granulocytes.
ers” was 4% within the population of GFP high cells and
60% within that of GFP low cells (Figure 1E). In Vitro Reprogrammed Cells Resemble
Macrophages Based on Morphology
and Phagocytic CapacityTracing the Reprogrammed Cells to B Cells Using
a Cre Lox Lineage Ancestry Approach Next, we characterized the in vitro reprogrammed B
cells from CD19 ancestry mice in more detail. Six daysThe formation of biphenotypic intermediates (Figure 1D)
makes it unlikely that the resulting CD19Mac-1 cells after infection of CD19 bone marrow precursors with
C/EBP virus, 78% of the CD19Mac-1 cells also ex-arose by the selective outgrowth of contaminating my-
eloid precursors. However, we occasionally observed pressed Gr-1, a marker of granulocytes and a subset
of monocytes, and 66% expressed F4/80, a marker ofthe appearance of macrophages in control virus-infected
cultures kept for more than 1 week, a fact that could mature macrophages and myeloid dendritic cell precur-
sors (Hume et al., 2002). The reprogrammed cells alsoobscure the further analyses of the reprogrammed cells.
To get around this problem, we crossed CD19 Cre knockin exhibited dramatic morphological changes: while con-
trol virus-infected EYFP splenic B cells were small andmice with R26R-EYFP conditional reporter mice, in which
initiation of EYFP expression depends on Cre activity (Fig- lacked granules (Figure 3A), C/EBP-infected cells were
large and contained granules (Figure 3B). Likewise,ure 2A). In this cross (in the following called “CD19 an-
cestry mice”), EYFP is expressed in ca. 90% and 50% FACS analyses revealed that C/EBP-infected EYFP
cells exhibited mean forward/side scatter values of 624of CD19 spleen and bone marrow cells, respectively,
while essentially all Mac1 myelomonocytic cells are and 504, respectively, compared to 445 and 262 for the
B Cell Reprogramming
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Figure 1. Induction of Mac-1 Expression in B Cell Precursors Infected with a C/EBP Retrovirus
(A) Retroviral vectors used for infection (top, empty control vector; bottom, transcription factor [TF] encoding vector). Either GFP or hCD4
antigen was used as an indicator for infection. Dark blue boxes, retroviral LTRs; light blue boxes, IRES elements.
(B) FACS profiles of bone marrow cells before and after selection of CD19 cells, stained with Mac-1 and CD19 antibodies.
(C) Control virus-infected cells after 4 days culture, showing absence of CD19Mac-1 cells within the GFP cell gate (R1).
(D) C/EBP-infected cells showing increasing proportions of CD19Mac-1 cells as well as biphenotypic cells 2–4 days after infection.
(E) C/EBP-infected cells (day 4) with gates corresponding to C/EBP (R1), low (R2), and high (R3) cells. Numbers in quadrants indicate
percent marker-positive cells. FSC, forward scatter.
control virus-infected cells. When the S17 stromal cells CD19 and Mac-1 bone marrow cells (the latter con-
tained both monocytes and granulocytes). As can beplus remaining B cells were washed away, leaving
seen in Figures 3F–3H, while the three control fractionsstrongly adherent macrophages behind, these were
expressed all B cell markers tested, including the B cellfound to be phagocytic, including those that were EYFP
transcription factor genes EBF, Pax5, and E2A, cells of(inset in Figure 3B). As expected, control virus-infected
fraction 5 showed no expression of the E2A/EBF targetcells were negative in this assay.
genes RAG1, B29, Mb-1, 5, and V-pre-B nor that of
the transcription factors EBF, E2A, and Pax5 (there were
Gene Profiling Reveals Loss of Lymphoid Gene trace amounts of Mb-1 and E2A RNA). However, surpris-
Expression and Upregulation of Macrophage- ingly, they still expressed significant levels of the IL7-R
Specific Genes as well as PU.1 gene (a 2- to 3-fold reduction compared to B cell con-
To study the gene expression pattern and functional trols) not seen in the Mac-1 control fraction (Figure
properties of the reprogrammed cells, CD19 bone mar- 3F). They also showed expression of all five monocytic
row cells from CD19 ancestry mice were infected with markers tested, in particular M-CSFR, while the neutro-
either control virus (Figure 3C) or C/EBP/hCD4 virus phil markers scored negative except for one, G-CSFR,
(Figures 3D and 3E). Ten days later, cells in the indicated which was weakly expressed (Figures 3G and 3H). The
gates were sorted to yield control fractions 1–3. In addi- reprogrammed macrophages in fraction 5 also differed
tion, EYFPhCD4 cells (gate 4 in Figure 3D) were gated from the B cell precursors in that they expressed 3- to
to reveal the fully reprogrammed CD19Mac-1 cells 5-fold higher levels of PU.1 mRNA, reflecting similar
(Figure 3E). These were sorted for analysis (fraction 5). differences as seen between the CD19 and Mac-1
The RNAs of the four fractions were then analyzed by controls from bone marrow (Figures 3G and 3I). We
conclude that the in vitro reprogrammed cells resemblesemiquantitative RT-PCR in comparison to RNAs from
Cell
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Figure 2. Cre Lox Lineage Ancestry Approach to Show Reprogramming of B Cells into Macrophages In Vitro and In Vivo
(A) Strategy outlining the generation of CD19 ancestry mice.
(B and C) Bone marrow cells from a CD19 ancestry mouse gated on the EYFP population (B) and the EYFP population (C) after staining
with Mac-1 and CD19 antibodies.
(D) CD19 bone marrow cells from a lineage ancestry mouse infected with C/EBP-hCD4 virus and cultured for 5 days, showing cells marked
by CD19-Cre-mediated excision (EYFP-only cells, R1); EYFP-marked, infected cells (EYFPhCD4, R2), and unmarked, infected cells (hCD4
only, R3). Analysis of cells within these gates shows that, while the uninfected cells (R1) remain unchanged, the infected EYFP (marked R2)
and unmarked B lineage cells (R3) reprogrammed with similar frequencies.
(E) Spleen cells from a CD19 ancestry mouse gated on the EYFP population stained with Mac-1 and CD19.
(F) Purified CD19 spleen cells from CD19 lineage ancestry mice stained with IgM, IgD, IgG, kappa, and/or lambda chain antibodies.
(G) CD19 spleen cells from CD19 lineage ancestry mice infected with C/EBP virus for 3 days, showing reprogramming frequencies of the
infected, EYFP cells (R1 gate).
(H) B220 bone marrow cells of CD19 lineage ancestry mice were infected with C/EBP virus for 6 hr and transplanted into a sublethally
irradiated immunodeficient mouse, and bone marrow was isolated 6 days later. The proportion of reprogrammed EYFP cells is shown for
cells present in gate R1 of one representative animal.
(I) Same as (H) but using the spleen for analysis.
(J) EYFPhCD4 spleen cells from a mouse transplanted with control virus-infected cells.
macrophages by morphological and functional criteria immunoglobulin rearrangements. We detected both
heavy chain DJ (Figure 3J) and VDJ rearrangementsas well as by their gene expression profiles.
(Figure 3K and data not shown) in the reprogrammed
macrophages but not in control bone marrow-derivedThe Reprogrammed Macrophages Exhibit Both
Heavy and Light Chain Immunoglobulin macrophages. Selected bands were excised and a total
of 35 clones sequenced, revealing 12 distinct VDJ re-Rearrangements
During differentiation in the bone marrow, B cells un- arrangements, of which four were in-frame. These in-
cluded both proximal and distal V family membersdergo a series of heavy and light chain rearrangements.
Cells with in-frame heavy chain VDJ rearrangements go ([Chevillard et al., 2002], see Supplemental Table S1 at
http://www.cell.com/cgi/content/117/5/663/DC1).on to rearrange their kappa or lambda light chains and
display IgM on their surfaces. We therefore determined The reprogrammed macrophages also exhibited kappa
chain rearrangements not seen in the control macro-whether the reprogrammed macrophages derived from
the B cell precursors of CD19 ancestry mice contain phages (Figure 3L and data not shown). Three bands
B Cell Reprogramming
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were excised, and five distinct VJ rearrangements were the uninfected cell population. As shown in Figure 5B,
this result could be confirmed when CD19 cells wereobserved among 27 kappa clones tested, two of which
were in frame (Supplemental Table S2). infected with PU.1 virus only. The results in this figure
also indicate that, unlike C/EBP, enforced expression
of PU.1 does not lead to the rapid downregulation ofDownregulation of the Early B Cell Marker
CD19. Finally, the data in Figures 5C and 5D show thatB220 Is Delayed
coinfection of C/EBP with PU.1 accelerates the forma-To gain more insights into the reprogramming process
tion of Mac-1-expressing cells without modifying theinduced by C/EBP, we monitored the C/EBP-induced
kinetics of CD19 downregulation. In conclusion, thesecell surface antigen changes over time. The kinetics in
data show that PU.1 synergizes with C/EBP in repro-Figure 4A shows that CD19 was downregulated more
gramming “nonresponders” and that the two factorsrapidly than was B220. Conversely, the proportion of
cooperate in the activation of Mac-1 expression.Mac-1 cells increased more rapidly than Gr-1 cells,
reaching a plateau at day 5. When plotting relative fluo-
rescence intensities instead of percentage positive cells Mac-1 Activation but Not CD19 Downregulation
(Figure 4B), the differences between CD19 and B220 Requires Endogenous PU.1
became even more significant, showing an 70% re- To test whether the induced B to M conversion requires
duction of CD19 expression at day 2, while B220 expres- endogenous PU.1, we expressed C/EBP in a PU.1-
sion was slightly increased at this time point. defective pre-B cell line recently developed in our labo-
ratory. This fetal liver-derived cell line expresses CD19
as well as most B cell-specific genes tested, includingC/EBP Also Reprograms B Cells
Pax5 and low levels of IL-7R but not B220, and alsoand Induces Cell Growth
exhibits DJ and VDJ rearrangements (M.Y. and T.G.,Since C/EBP is known to be functionally redundant
unpublished data). The cells were infected with eitherwith C/EBP within the hematopoietic system (Jones et
C/EBP or PU.1 virus alone or with a combination ofal., 2002), we tested whether enforced expression of
both and then analyzed 2–4 days later by gating on theC/EBP can also induce the reprogramming of B cell
infected cells. As a control, cells were infected with theprecursors. The results in Figure 4C show that this is
corresponding control virus. As can be seen in Figurethe case. Comparison of the two transcription factors in
5E, CD19 expression was downregulated by C/EBPthe same experiment revealed that the C/EBP-induced
alone and by C/EBP plus PU.1 at similar efficienciesMac-1 upregulation was slightly faster, while the down-
but not by PU.1. Conversely, while neither PU.1 aloneregulation of CD19 was very similar for both factors
nor C/EBP led to an upregulation of Mac-1 expression,(Figure 4D). The majority of the cells reprogrammed by
68% of the double-infected cells expressed the antigenC/EBP, as with C/EBP, expressed Gr-1 and F4/80
after 4 days (Figure 5F). Finally, while PU.1 alone didantigens (data not shown). Remarkably, while the per-
not up regulate Gr-1 expression, 23% of the cells in-centage of C/EBP-infected cells decreased over time,
fected with C/EBP expressed the antigen at day 4the percentage of C/EBP-infected cells increased sig-
compared to 83% of cells infected with C/EBP plusnificantly in comparison to uninfected and control virus-
PU.1 (Figure 5G). The control virus showed no effect,infected cells (Figure 4E).
while very similar results as with C/EBP were obtained
when C/EBP virus was used for double-infection ex-Exogenous PU.1 Collaborates with C/EBP
periments (data not shown). These data show that induc-in B Cell Reprogramming
tion of Mac-1 (and to a lesser extent Gr-1) expressionSince C/EBP and PU.1 are known to coregulate many
by C/EBP requires endogenous PU.1, while its capacitymacrophage-specific genes, a plausible explanation for
to induce CD19 downregulation does not. They alsothe rapid C/EBP-induced reprogramming is that it does
confirm our observation that high levels of PU.1 do notso by synergizing with endogenous PU.1. Based on this
inhibit CD19 expression.assumption, the C/EBP nonresponders might represent
cells that express subthreshold levels of PU.1 and thus
should be reprogrammable when coinfected with both Expression of Endogenous Mac-1 Is Activated
in Fibroblasts by a CombinationC/EBP and PU.1 viruses. To test this, CD19 bone
marrow cells were coinfected with C/EBP/hCD4 and of C/EBP and PU.1
The above experiments raised the possibility thatPU.1/GFP virus. The cells were then analyzed by FACS
at various times after infection and single- and double- C/EBP, together with PU.1, directly activates expres-
sion of the Mac-1 gene. However, while the Mac-1 pro-infected as well as uninfected cell populations gated. As
can be seen in Figure 5, the proportion of reprogrammed moter has been described to contain PU.1 binding sites
and to be PU.1 responsive, it was not reported to contain(CD19Mac-1) cells increased from 57% in C/EBP
only (R1) to 92% in the double-infected population (R2). C/EBP binding sites (Pahl et al., 1993). Since, in these
studies, only a 93 bp upstream fragment was tested, itMore strikingly, the proportion of nonresponders de-
creased from 32% to 1.5% in the double-infected popu- seemed possible that C/EBP-responsive sites are pres-
ent elsewhere in the Mac-1 promoter/enhancer. To testlation. This effect is probably not due to the selective
death of the nonresponders by high PU.1 expression, this, we infected NIH3T3 fibroblasts with a combination
of C/EBP and PU.1 and analyzed the cells by FACS 4since similar survival rates were observed with single-
and double-infected cells (data not shown). Unexpect- days later, gating on double- as well as single-infected
cells. As shown in Figure 5H, the combination of C/EBPedly, 9% of the PU.1-only-infected cells (R3) also be-
came CD19Mac-1, while no such cells were seen in and PU.1 strongly activated Mac-1 expression (about
Cell
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Figure 3. Phenotype of Reprogrammed Cells
(A and B) Morphology of CD19 spleen cells from CD19 ancestry mice infected and cultured for 10 days with either control virus or C/EBP
virus, respectively, showing EYFP cells in yellow. The inset shows cells that have ingested red fluorescent beads, with nuclei stained blue
with Hoechst 33342. Bars represent 20 m.
(C–E) Cells used for RT-PCR analysis. CD19 bone marrow cells from CD19 ancestry mice were infected with control (C) or C/EBP virus (D),
cultured for 10 days, and analyzed by FACS, following staining with CD19 and Mac-1 antibodies. Cells in gates 1, 2, and 3 were sorted and
served as negative controls. In addition, EYFPhCD4 cells in gate 4 (D) were plotted to reveal EYFPCD19Mac-1 cells (E) that were sorted
for analysis (fraction 5).
(F–H) RT-PCR analysis of fractions 1, 2, 3, and 5, using the primers that detect the indicated genes ([F], B-lymphoid; [G], macrophage; [H],
B Cell Reprogramming
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60% of the cells showed a 30-fold increase in fluores- Can Mature B Cells Be Reprogrammed by C/EBP?
cence intensity compared to uninfected control cells), Our data indicate that at least 30% of the infectable
while PU.1 alone weakly induced Mac-1 expression, and immunoglobulin-expressing splenic B cells can be re-
C/EBP had essentially no effect (Figures 5I and 5J). programmed by enforced C/EBP expression. We do
Although we have not delineated the C/EBP-responsive not think that this observation can be explained by the
element in the regulatory region of the Mac-1 gene, our selective outgrowth of a contaminating non-B lineage
data are consistent with the notion that the gene is population since (1) the purified CD19 cells used for
activated by the concerted action of PU.1 and C/EBP. infection, obtained from the CD19 ancestry mouse (which
do not exhibit EYFP expression in any myeloid cells), were
99.2% pure and contained 	0.1% Mac-1 cells; (2) two
C/EBP but Not PU.1 Inhibits the Capacity of Pax5 days after C/EBP infection, 15% of the cells became
to Activate the CD19 Promoter Mac-1, while 10% expressed intermediate levels of
The rapid downregulation of CD19, a direct target of both CD19 and Mac-1 (data not shown); and (3) we did
Pax5 (Kozmik et al., 1992; Schebesta et al., 2002), raised not detect significant differences in the cell cycle status
the possibility that C/EBP antagonizes Pax5 activity. between the reprogrammed and the nonreprogrammed
We therefore transfected a CD19 promoter luciferase cells in the C/EBP-infected samples 3 days after infec-
reporter construct containing a 1.3 kb upstream frag- tion (not shown). Our data also suggest that every single
ment of the human CD19 gene into 293 cells (a kidney- CD19/Mac-1 cell that was seen after C/EBP expres-
derived human fibroblastoid cell line) together with dif- sion (Figure 2G) is derived from an immunoglobulin-
ferent concentrations of Pax5 DNA. As shown in Figure expressing cell, since essentially all of the EYFP cells
6A, the luciferase activity increased gradually, reaching in these mice express IgM, IgD, or IgG. Finally, the repro-
an approximately 2.5-fold increase at 0.05 g of Pax5 grammed B cells correspond to functional macro-
DNA. Although this increase was modest, it was highly phages, as illustrated in Figures 2A and 2B. The plastic-
reproducible. No activation of the reporter was seen ity of B cells is surprising, since common lymphoid
with C/EBP, PU.1, or FOG-1 DNA (Figures 6B and 6C progenitors as well as pro-T (pro-T1) cells can be con-
and data not shown). When the cells were cotransfected
verted into myeloid cells after ectopic expression of
with 0.05 g Pax5 DNA plus increasing amounts of a
human IL-2 or GM-CSF receptor, while this was no
plasmid encoding C/EBP, PU.1, or FOG-1, the lucifer-
longer possible with either pre-T (pro-T2) cells or pro-B
ase reporter was inhibited by C/EBP but not by PU.1
and pre-B cells (Iwasaki-Arai et al., 2003; King et al.,or FOG-1 (Figures 6D–6F). C/EBP, like C/EBP, was
2002; Kondo et al., 2000).also found to inhibit Pax5 activity (data not shown). Since
the same expression vectors were used for both Pax5
and C/EBP, it is unlikely that the effects observed re-
What Myeloid Cell Types Are Generated?sulted from the inhibition of Pax5 expression. In conclu-
That the in vitro reprogrammed B cells resemble macro-sion, our results suggest that C/EBP (and C/EBP)
phages was surprising, since C/EBP is believed to playspecifically inhibit Pax5 activity on the CD19 promoter.
a role in the formation of granulocytes but not of macro-
phages. Thus, enforced C/EBP expression in HL60
cells converts them into neutrophil granulocytes (Ra-Discussion
domska et al., 1998), and C/EBP transforms E26-MEP
cells into eosinophil granulocytes. In contrast, both PU.1Our results show that B cells can be rapidly and effi-
and C/EBP convert E26-MEP cells into macrophageciently reprogrammed to become macrophages after
precursors (Nerlov and Graf, 1998; Nerlov et al., 1998).enforced expression of C/EBP or C/EBP transcription
We cannot rule out the possibility that the lack of granu-factors. We were able to follow cell surface marker
locytes observed in the present work is a result of thechanges in large cell populations over time (Figure 7A)
culture conditions used, although macrophages wereand to correlate them to modulations in the activity of
also obtained when GM-CSF and G-CSF were addedkey transcription factors acting on the promoters of rele-
to the S17 stromal cultures (which produce M-CSF).vant lineage marker genes (Figure 7B). C/EBP initiates
The phenotype of both C/EBP- and C/EBP-repro-the reprogramming process by simultaneously down-
grammed cells (Mac-1, F4/80, Gr-1, and L-selectin) isregulating late lymphoid marker(s) and upregulating my-
characteristic of inflammatory-type monocytes (Geiss-eloid markers. Subsequently, one or more reprogram-
mann et al., 2003), perhaps reflecting the fact thatming waves lead to the complete extinction of early
C/EBP becomes activated in monocytes during inflam-lymphoid markers and the generation of functional mac-
rophages. matory responses (Poli, 1998).
neutrophil restricted genes). BM CD19 and BM Mac-1 are control fractions isolated from fresh bone marrow, containing B lineage cells
and granulocytes/macrophages, respectively.
(I) Relative expression levels of PU.1, as determined by densitometry of samples analyzed by semiquantitative RT-PCR relative to  actin
used as internal control.
(J–L) Immunoglobulin rearrangements of EYFPCD19Mac-1 reprogrammed cells. The first lane (Sp) shows DNA from spleen cells, the
middle lane (Mφ) corresponds to DNA from bone marrow-derived macrophages, and the last lane (Rep) corresponds to EYFPCD19Mac-1
reprogrammed cells. (J), heavy chain DJ rearrangements. (K), heavy chain VDJ rearrangements. (L), kappa light chain VJ rearrangements.
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Figure 4. Reprogramming Kinetics of C/EBP and -Infected B Cell Precursors
(A) CD19 precursors were infected with C/EBP virus and percent antigen-positive cells scored at different times. CD19, dark blue; B220,
light blue; Mac-1, green; Gr-1, red.
(B) Same as in (A), except that fluorescent intensities of infected versus uninfected cells (100%) were plotted.
(C) CD19 bone marrow cells infected with C/EBP virus and cultured for 2–4 days.
(D) Comparison of C/EBP- and C/EBP-induced CD19 downregulation and Mac-1 upregulation. Pink lines, cells infected with C/EBP
virus; black lines, cells infected with C/EBP. Solid lines, CD19; broken lines, Mac-1. Similar differences in the kinetics were observed in
another experiment.
(E) Percentage of infected cells recovered over time, relative to the percentage of infected cells at day 2. Black line, C/EBP virus; orange
line, control virus; pink line, C/EBP virus-infected cells. All experiments were done in triplicate wells, with values showing the means and
standard deviations.
C/EBP versus C/EBP be determined. Another important question that needs
to be addressed is why the apparent upregulation ofOur data show that C/EBP is capable of reprogram-
ming B cells at similar efficiencies as C/EBP (60% full-length C/EBP during normal B cell development
(Cooper et al., 1994) does not lead to their reprogram-of infected B cell precursors). However, the two proteins
differ in that enforced expression of C/EBP leads to cell ming into macrophages.
loss, while C/EBP-overexpressing cells are induced to
proliferate. This suggests that the rate of cell division is Parallel and Sequential Reprogramming
Mechanisms Induced by C/EBPirrelevant for the reprogramming process and that the
percentages of induced macrophages observed reflect Our data indicate that C/EBP acts by a two-pronged
approach (Figure 7B) by downregulating the late B cell-the actual reprogramming frequency. The growth-arresting
potential of C/EBP and the proliferation-inducing po- specific marker CD19 through inhibition of Pax5 on the
one hand and by upregulating myeloid genes on thetential of C/EBP have been described before for a num-
ber of cell systems. For example, during hormonally other. The observed synergism between C/EBP with
PU.1 is in line with the fact that most myeloid promotersinduced adipocyte differentiation of preadipocytes,
C/EBP induces mitotic clonal expansion, followed by require both C/EBP and PU.1 for efficient activation
(Friedman, 2002; Tenen et al., 1997). Likewise, our stud-the activation of C/EBP, terminal differentiation, and
growth arrest (Tang et al., 2003). Whether C/EBP also ies support reports that C/EBP can activate PU.1 ex-
pression and that PU.1 can positively regulate its ownactivates C/EBP expression in our system remains to
B Cell Reprogramming
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Figure 5. Role of PU.1 in C/EBP-Induced Reprogramming
(A–D) Effects of double infection with C/EBP and PU.1 viruses on B cell reprogramming efficiency and Mac-1 upregulation. (A) CD19 bone
marrow precursors were coinfected with PU.1-GFP and C/EBP-hCD4 virus and analyzed 4 days later. Profile on the left shows C/EBP virus-
only-infected cells (R1), double-infected cells (R2), and PU.1 virus-infected cells (R3). The corresponding phenotypes are shown in the three
profiles to the right. (B) CD19 cells singly infected with PU.1 virus 2 and 4 days after infection. (C) Kinetics of CD19 and (D), Mac-1 antigen
expression of cells shown in (A). Red curves, double-infected cells; blue curves, C/EBP virus-only-infected cells. CD19 values correspond
to relative mean fluorescent intensity and Mac-1 values to percent CD19Mac-1 infected cells.
(E–J) PU.1-independent and PU.1-dependent changes induced by C/EBP. (E–G) PU.1/ pre-B cells were coinfected with C/EBP-hCD4 and
PU.1-GFP virus, and singly and doubly infected cells were gated at various times thereafter and analyzed for expression of CD19 (E), Mac-1
(F), and Gr-1 (G). Red lines, double-infected cells; green lines, PU.1-infected cells; blue lines, C/EBP-infected cells. (H–J) NIH3T3 fibroblasts
were coinfected with C/EBP-hCD4 and PU.1-GFP virus and analyzed for Mac-1 antigen expression 4 days later. The data show overlayed
histograms of uninfected control cells (gray lines) with the infected cells, colorcoded as in (E)–(G).
(high-level) expression in macrophages (reviewed in not only exhibit an extinction of the Pax5-regulated
CD19 gene but also that of the early regulators EBF andFriedman [2002]). The antagonism of C/EBP toward
Pax5 has not been described before. It will be interesting E2A as well as of a number of their downstream targets,
including Pax5. Their extinction, on the other hand, can-to determine its mechanism.
Several observations suggest that at least one addi- not be explained by the inactivation of Pax5 alone, since
the protein is neither known to regulate its own expres-tional reprogramming event is required for the comple-
tion of the C/EBP-induced B to M conversion. First, sion nor to activate E2A or EBF. In addition, Pax5/
pro-B cells express B220 and maintain their lymphoidthere is a 2 day delay in the downregulation of the early
B cell antigen B220 compared to CD19 (Figure 4B). Since identity when maintained in the presence of IL-7, al-
though a number of myeloid genes are derepressedB220 is an alternatively spliced form of CD45, a panhe-
matopoietic marker which we found to be expressed in (Nutt et al., 1999). We therefore postulate that an addi-
tional, early B cell regulator becomes inactivated duringreprogrammed macrophages, this is likely to reflect the
inactivation of a B lineage-specific component of the splic- the reprogramming process. This might happen through
yet another direct action of C/EBP or indirectly, suching machinery. Second, reprogrammed macrophages
Cell
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Figure 6. Effects of C/EBP and PU.1 on the Pax5-Mediated Activation of the CD19 Promoter
293 cells were cotransfected with a reporter plasmid consisting of a 1.3 kb upstream fragment of the human CD19 promoter linked to the
firefly luciferase gene, together with transcription factor-encoding retroviral vectors and a -gal control plasmid. (A–C) Effect of increasing
concentrations of Pax5, C/EBP, and PU.1 DNA on the CD19 promoter. (C–F) Effects of increasing concentrations of C/EBP, PU.1, and
FOG-1 DNA on suppression of the ability of Pax5 to drive the expression of the CD19 promoter. Values shown, corrected for transfection
efficiency, correspond to means 
SD obtained from three separate wells.
as through PU.1 expressed at elevated levels (Figure age of endogenous PU.1 also matters. The fact that
7B). We favor the latter possibility, because enforced C/EBP-induced upregulation of myeloid genes strictly
expression of PU.1 on its own can reprogram a propor- requires PU.1 and that C/EBP nonresponders can be
tion of early B cell precursors, showing a delayed down- reprogrammed through coinfection with PU.1 (Figure
regulation of CD19 expression compared to C/EBP- 5A) suggests that the latter express subthreshold levels
infected cells and because it is unable to inactivate Pax5 of endogenous PU.1. In addition, initially, some respond-
on the CD19 promoter. Experiments with inducible ver- ers predominantly downregulate CD19, while others
sions of C/EBP should offer further insights into the predominantly upregulate Mac-1 (Figure 1D). This could
sequential extinction of the B cell gene expression pro- be explained by the assumption that the former express
gram and whether B cells become irreversibly commit- relatively low levels of endogenous PU.1 before infec-
ted to a myeloid fate after a limited exposure to exoge- tion, resembling PU.1/ cells in their response to
nous C/EBP. Similar experiments with chicken MEP C/EBP (Figures 5E–5G), while the latter represent cells
cells have revealed that a 2–3 day activation of exoge- with relatively high levels of PU.1, resembling C/EBP/
nous C/EBP or PU.1 is sufficient to induce their com- PU.1 double-infected cells (Figure 5A) in their response.
mitment into either eosinophils or myeloid cells, respec- However, we cannot rule out the possibility that the
tively (Nerlov and Graf, 1998; Nerlov et al., 1998). observed heterogeneity in the C/EBP response reflects
differences between individual cells in CD19 degrada-
tion and Mac-1 synthesis rates.Role of Dosage
Our results indicate that the B to M conversion frequency A role of transcription factor dosage for lineage deter-
mination has been suggested earlier, such as for GATA-1depends on the dosage of C/EBP. In addition, the dos-
B Cell Reprogramming
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Figure 7. Summary of the Observed B Cell to
Macrophage Conversion
(A) Changes occurring at the cell surface after
infection of a CD19-expressing B cell with a
C/EBP virus. The cell is shown to turn into
Mac-1 after passing through an intermedi-
ate that expresses low levels of CD19 and
Mac-1 antigen. CD19, red circles; Mac-1,
green squares.
(B) Changes occurring inside the nucleus.
Straight arrows and T-shaped bars indicate
activation and inhibition, respectively. Curved
arrow, autoregulation; open arrows, up- or
downregulation. Dashed lines indicate uncer-
tainty.
levels determining the decision between eosinophil and gether with PU.1high drive the expression of macrophage-
specific genes and also regulate each other as well asMEP cell formation (Kulessa et al., 1995) and of PU.1
levels for B cell and macrophage formation (DeKoter themselves, thus maintaining high levels of expression
(Friedman, 2002; Nerlov and Graf, 1998; Tenen et al.,and Singh, 2000). The balance between the dosages of
PU.1 and C/EBP has also been shown to be important 1997). From this perspective, our data suggest that en-
forced expression of C/EBP in B cells alters the configu-for the formation of macrophages versus granulocytes
in vivo (Dahl et al., 2003). It was recently reported that ration of the B cell transcription factor network by simul-
taneously modulating the activity and level of two of itsC/EBP can reprogram pro-B cells derived from Pax5/
but not from wild-type mice (Heavey et al., 2003). This components (Pax5 and PU.1). We speculate that, under
the influence of high PU.1 levels, this intermediate net-discrepancy might either be due to differences in culture
conditions or to C/EBP expression levels achieved. We work configuration is not stable, resulting in the for-
mation of a macrophage-specific transcription factorfavor the latter explanation, since, in our study, only
B cells with high levels of ectopic C/EBP expression network. The new configuration is then stabilized by
auto- and crossregulation of PU.1 and C/EBP gene ex-became efficiently reprogrammed. The present work,
together with experiments showing that the expression pression. Our data suggest that the choice of a fetal
liver precursor to become either a B cell or a macro-of myeloid genes (such a M-CSFR) is activated when
Pax5 is ablated in pro-B cells (Mikkola et al., 2002), phage might obey similar rules. It is possible that, in
these progenitors, both C/EBP and Pax5 are expressedindicates that C/EBP and Pax5 act in a cross-
antagonistic manner. In support of this is the observa- at low levels and that during differentiation, one factor
becomes dominant through the mechanism described.tion that coinfection of B cell precursors with C/EBP
and Pax5 leads to a reduced reprogramming frequency
compared to C/EBP alone (our unpublished data). Sim- Does the B Cell to Macrophage Conversion
Recapitulate a Pathological Process?ilarly, work with hematopoietic cell lines has shown that
the balance of GATA-1 and PU.1 and of FOG-1 and The speed and efficiency with which B cell precursors
can be reprogrammed by C/EBP (and C/EBP) raiseC/EBP determines whether cells become committed to
either the erythroid or myelomonocytic lineages (Cantor the question as to whether this process can be induced
under pathological conditions. Thus, infection of B cellsand Orkin, 2001; Graf, 2002), with cells capable of differ-
entiating in both directions. with specific pathogens, or other stresses that activate
signaling pathways, might activate C/EBP or C/EBP
and convert them into macrophages. In this context, itInduced Remodeling of a Transcription Factor
Network: A Model for Normal Differentiation? is interesting that reprogramming of pro-T1 cells into
myeloid cells by ectopic GM-CSFR signaling is accom-Hematopoietic lineages are established and maintained
by cell type-specific regulatory circuits or transcription panied by C/EBP expression (Iwasaki-Arai et al., 2003).
Our finding that even relatively mature B cells retainfactor “networks” (Sieweke and Graf, 1998; Warren and
Rothenberg, 2003). Thus, during B cell commitment, the considerable plasticity may also be relevant for the
pathogenesis of leukemia. Thus, some myeloid leuke-combination of E2A with EBF drives Pax5 expression,
and all three factors regulate the expression of genes mias exhibit immunoglobulin gene rearrangements
(Mirro et al., 1986). Also, Hodgkin’s lymphoma cells,in differentiated cells (for review, see Hardy [2003] and
Schebesta et al. [2002]). Likewise, C/EBP and/or  to- which express some genes shared with monocytic and
Cell
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FACS Sorting and Semiquantitative RT-PCRdendritic cells but lack most B cell markers, typically
Reprogrammed cells derived from CD19 ancestry mice (EYFPhCD-contain immunoglobulin rearrangements and somatic
4CD19Mac-1) cultured for 10 days were sorted in a MoFlo cellhypermutations (Kuppers et al., 2002), suggesting a ger-
sorter (Cytomation). Control populations were also sorted. Total
minal center B cell origin. RNA was extracted from each population as well as from MACS-
purified CD19 or Mac-1 cells using Trizol (Life Technologies). RNA
Experimental Procedures was digested with RNase-free DNase I (Roche) to remove contami-
nating genomic DNA. Then first-strand cDNA was synthesized with
Mouse Strains and Purification of B Lineage Cells SuperScript II RNase H reverse transcriptase using oligo (dT)12–18
CD19 Cre-ROSA EYFP mice (/Ki, /Ki) have been described pre- primer (Life Technologies). Concentration of cDNA in different sam-
viously (Ye et al., 2003). RAG2/c/ mice were purchased from ples was calibrated by  actin cDNA. PCR reactions were run at
Taconic. To obtain B cell precursors, bone marrow cells from 94C for 2 min (denaturation) followed by 94C for 30 s, 60C for
5-week-old mice were harvested from hindleg bones. After lysis of 30 s, and 72C for 30 s for 26–33 cycles (amplification), depending on
erythroid cells, they were suspended in PBS with 4% FCS and the relative abundance of mRNA from different genes. PCR products
incubated with Fc-block (BD Pharmingen) for 10 min followed by were resolved on agarose gels and visualized by ethidium bromide
20 min incubation on ice with biotinylated anti-mouse CD19 or B220 staining. Images were taken by ChemiImager 4400 (Alpha Innotech
antibodies (BD Pharmingen). Cells were washed with PBS/2 mM Corporation) and quantitated with ImageQuant V1.2 software (Mo-
EDTA twice and then resuspended at 107 cells/90 l. To this, 10 l lecular Dynamics). For primers used, see Supplemental Table S3.
of streptavidin-coated microbeads were added and incubated on
ice for 20 min. After two washes with PBS/FCS, cells were pelleted
Immunoglobulin Gene Rearrangements
and resuspended at 108 cells/500 l. Cell separations were carried
Reprogrammed cells from CD19 ancestry mice (cultured for 18 days)
out with Auto-MACS (Miltenyi Biotech) using the POSSELD program.
were sorted as above. As a control, adherent macrophages
Sorted cells were stained with PE-CD19, APC-Mac-1 antibodies (BD
(CD19Mac-1) derived from bone marrow cultured under the same
Pharmingen), and analyzed by flow cytometry on a FACSCalibur
conditions were also sorted. Freshly isolated spleen cells were used
(BD Biosciences).
as another control. Genomic DNA was extracted using DNeasy Tis-
sue Kit (Qiagen). DNA from about 600 reprogrammed cells and 1600
Transcription Factor-Encoding Vectors
control macrophages cells was used for PCR reactions. These were
Retroviruses encoding full-lengh cDNAs of murine PU.1, C/EBP,
run at 94C for 2 min (denaturation) followed by 94C for 15 s, 60C
and Pax5 (Nerlov and Graf, 1998; Nerlov et al., 1998) were cloned
for 30 s, and 72C for 60 s for 40 cycles (amplification). For DHJHby PCR into the BglII/XhoI sites of the pMIG retrovirus vector by
rearrangements, the primer pair DFS and JH4A was used. For VHDHJHcreating a BglII site on the 5 end and a XhoI site at the 3 end,
rearrangements, VHA, VHB, VHC, VHD, VHE, and VHF 5 primers werewhile full-length murine C/EBP (gift from Dr. Philip Scherer) was
used in separate reactions together with JH4E as a 3 primer (Ehlichinserted into the EcoRI site of the vector. The hCD4 virus vector
et al., 1994). The primers for kappa light chain rearrangement V,was generated by removing the GFP sequence from pMIG with
J2, J5 were as described (ten Boekel et al., 1995). PCR productsNcoI/SalI and inserting a truncated hCD4 excised from pMACS4.1
were resolved on agarose gels and visualized by ethidium bromide
(Sigma) by NotI/HindIII using blunt end ligation. MMP-HA-FOG was
staining. Images were taken by ChemiImager 4400 (Alpha Innotech
a gift from Dr. Stuart Orkin.
Corporation). DNA bands corresponding to VHAJH3, VHEJH2, VHEJH4,
VHFJH4, VJ1, VJ2, and VJ5 were cloned and verified by se-Retrovirus Production, Infection, Cell Culture,
quencing.
and Transplantation
Retrovirus stocks were prepared by transient transfection of Phoe-
Cell Linesnix-Eco cells (gift from Dr. Garry Nolan) using Lipofectamine Plus
The S17 stromal cell line was a gift from Dr. Gordon Keller. The(Life Technologies), and supernatants were harvested 48 hr later.
PU.1/ cell line was derived from a conditional knockout mouseFor infection, purified B cells were resuspended at 5  105 cells/ml
line (Drs. H. Iwasaki, D. Tenen, and K. Akashi, personal communica-in RPMI1640 with 10% FCS, 5.5  105M 2-mercaptoethanol as
tion), in which exons 4 and 5 were removed by crossing it with a well as 10 ng/ml each of IL-3, IL-7, Flt-3, SCF, and M-CSF (R&D
actin Cre mouse. The particular cells used were derived from a 16Systems). Then, 2 ml aliquots were deposited into a 12-well plate
day fetal liver and had been maintained on irradiated S17 cells plusprecoated with retronectin (Takara) followed by 2 ml of retrovirus
10 g/ml SCF, 10 g/ml IL-3, and 5 g/ml IL-7 for 5 months. Itssupernatant to which polybrene (Sigma) was added (8 g/ml). The
lack of exons 4 and 5 was confirmed by PCR.plates were centrifuged for 60 min at 700  g, followed by 3–6 hr
of incubation at 32C. Infected cells were then transferred onto
CD19 Promoter Reporter Assayirradiated (3000 rad) S17 stromal cells supplemented with 10 ng/ml
The CD19 promoter reporter (Kozmik et al., 1992) (gift from Dr.of IL-3, IL-7, Flt-3, SCF, and M-CSF or transplanted intraven-
Meinrad Busslinger) contains a 1.3 kb fragment of the human CD19ously (4  106 cells/mouse) into sublethally irradiated (280 rad)
promoter sequence linked to firefly luciferase cDNA and insertedRAG2/c/ mice.
into the plasmid pSP64. CD19-Luc reporter plasmid (0.3 g) was
used for transfection of 293 cells grown in 12-well plates. CMV-FACS Analysis and Phagocytosis Assay
-gal (0.05 g) was used as an internal control. To test dosageBiotinylated antibodies against CD19, B220, Mac-1; PE-labeled
effects, 0.01, 0.05, 0.1, and 0.3 g of Pax5, C/EBP, PU.1, andCD19, B220, Mac-1, Gr-1; and APC-labeled B220, Mac-1, Gr-1, and
FOG-1 DNA in pMIG retrovirus vector were adjusted to a total ofL-selectin antibodies were purchased from BD Pharmingen; PE-
0.3 g DNA with control pMIG vector DNA. For inhibition experi-Cy7-hCD4, APC-F4/80 from Caltag; and PE-conjugated anti-IgM,
ments, 0.05 g of Pax5 expression vector was transfected together-IgD, -IgG, -Ig kappa, and -Ig lambda from Southern Biotechnology
with 0.05, 0.1, and 0.25 g of C/EBP, PU.1, and FOG-1 DNAs. AfterAssociates, Inc. Stained cell samples were run on FACScalibur and
transfection (36–48 hr), cells were lysed with 250 l of passive lysisLSRII (BD Biosciences) machines and data analyzed with FlowJo
buffer (Promega) and 20 l of the lysate used to measure luciferasesoftware (Tree Star). For phagocytosis assays, S17 stromal cells
activity (luciferase substrate was from Promega Life Sciences) usingand B cells were removed from C/EBP-infected cultures (18 days
AutoLumat Plus LB 953 luminometer (Berthold Technology). Anotherpostinfection) by vigorous pipetting. The remaining adherent cells
20 l was used to measure -galactosidase activity to calibratewere incubated with 0.5 l of 1 m red fluorescent carboxylated
luciferase values. All samples were tested in triplicate.microspheres (Molecular Probes) for 1 hr at 37C in RPMI 1640 plus
10% FCS and 10 ng/ml M-CSF. The cells were then thoroughly
washed, stained with Hoechst 33342, and photographed using En- Acknowledgments
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